Supply Chain
GE HealthCare Will Pay $945 Million for SOFIE Biosciences to Own the Final Mile of PET Tracer Supply
The all-cash deal brings 15 contract-manufacturing sites and 21 cyclotrons, and GE HealthCare expects it to add to revenue growth and earnings in the first full year.
PR
By Priya Raghavan
Oct 5, 2026 · 2 min read
GE HealthCare said Monday it had agreed to acquire SOFIE Biosciences from Trilantic North America for $945 million in cash, buying a U.S. manufacturing network for positron emission tomography radiopharmaceuticals.
Discussion (0)
Sign in to join the discussion.
Loading comments…
PR
Priya Raghavan
Corporate Insider Inc.
Priya Raghavan writes for Corporate Insider Inc.